INNATE PHARMA SA-SPONS ADR (IPHA)

US45781K2042 - ADR

2.5454  +0.12 (+4.75%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to IPHA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.03. This target is 176.02% above the current price.
IPHA was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IPHA.
In the previous month the buy percentage consensus was at a similar level.
IPHA was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 2.552.386.797.0314.30 - -6.47% 166.58% 176.02% 461.80%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-04-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-16 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-24 HC Wainwright & Co. Reiterate Buy
2022-11-15 SVB Leerink Maintains Outperform
2022-09-16 Citigroup Maintains Buy
2022-08-02 SVB Leerink Maintains Outperform
2022-05-11 SVB Leerink Maintains Outperform
2021-09-17 SVB Leerink Maintains Outperform
2021-09-03 SVB Leerink Upgrade Market Perform -> Outperform
2021-09-02 SVB Leerink Upgrade Market Perform -> Outperform